Metabolic dysfunction-associated steatotic liver disease (MASLD), nonalcoholic fatty liver disease (NAFLD), and fatty liver disease all describe conditions where too much fat builds up in the liver, ...
Please provide your email address to receive an email when new articles are posted on . No statistically significant differences were found for MASH or cardiovascular disease outcomes between lean and ...
In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...
Please provide your email address to receive an email when new articles are posted on . VANCOUVER, British Columbia — Despite recent changes in nomenclature for metabolic dysfunction-associated ...
Metabolic dysfunction–associated steatotic liver disease (MASLD) significantly raises the risk for cardiovascular, metabolic, oncologic, and other outcomes, a new meta-analysis suggests. Researchers ...
Abstract presenting 48-week IMPACT Phase 2b efficacy and safety data selected for inclusion in “Best of EASL 2026” by EASLOral presentation will ...
Credit: Getty Images Our easy-to-read fact sheet provides an overview of the relationship between metabolic dysfunction-associated steatotic liver disease and obesity. Our easy-to-read fact sheets ...
BOSTON — The nomenclature may have changed, but the steady rise in the most common form of liver disease — metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD) — ...
Lifestyle changes, medications, and emerging therapies can help treat or reverse metabolic dysfunction-associated steatotic liver disease (MASLD) for some people. Metabolic dysfunction-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results